Breaks Categories: News

TuesdayOct 13, 2020 9:45 am

NetworkNewsBreaks – Siyata Mobile Inc. (NASDAQ: SYTA) (TSX.V: SIM) Announces New Uniden Cellular Signal Booster VP of Sales for US

Siyata Mobile (NASDAQ: SYTA, SYTAW) (TSX.V: SIM), a leading global developer and provider of Push-to-Talk Over Cellular (“PTT/PoC”) systems for enterprise customers, has appointed a new U.S. vice president of sales for the company’s Uniden(r) cellular signal booster portfolio. LaRue Martz will take over the position effective immediately. An experienced sales exec, Martz has worked in various capacities in several leading telecommunications companies, including stints at Nextivity, Samsung Wireless and Huawei. Most recently, Martz was serving as director of sales at Nextivity, where he managed the FirstNet and AT&T accounts. He also worked for more than two decades at AT&T.…

Continue Reading

MondayOct 12, 2020 12:58 pm

NetworkNewsBreaks – Vivos Therapeutics Inc. Files Registration Statement for Proposed $20M Initial Public Offering

Vivos Therapeutics, a medical technology company that offers novel and proprietary alternatives for treating mild-to-moderate obstructive sleep apnea, on Friday announced that is has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to the proposed initial public offering of its common stock. According to the update, application has been made for listing the common stock on the Nasdaq Capital Market under the ticker symbol “VVOS.” The proposed $20,000,000 offering (not including the underwriters’ over-allotment option), which is subject to market conditions with no assurance as to its actual completion or terms, has…

Continue Reading

MondayOct 12, 2020 12:30 pm

NetworkNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Expands Stake in Changyi, Further Positions to Continually Enhance Smart Solutions

iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, today announced that it has increased its controlling interest in Changyi (Shanghai) Information Technology Co. Ltd. Changyi is a leading independent software vendor that provides intelligent retail and CRM solutions, through which iClick has further enhanced its data-driven Enterprise Solutions business. “Our clients are continually looking for ways to increase operational and marketing efficiencies as they tackle the challenges of doing business in China and the region,” iClick co-founder and CEO Jian "T.J." Tang said in the news release. “Through expanding our stake…

Continue Reading

MondayOct 12, 2020 11:58 am

NetworkNewsBreaks – Sugarmade Inc. (SGMD) Updates Shareholders on Two Key Initiatives

Sugarmade (OTCQB: SGMD), today issued a letter to its shareholders, on behalf of its CEO Jimmy Chan, that provided an update on coming expansion steps in regard to its BudCars delivery service as well as the company’s vertical integration. “Today, I want to highlight two themes that will help to drive our value proposition for shareholders over the intermediate term: geographic expansion for BudCars and our move to vertically integrate through the establishment of cultivation operations. Together, they represent tangible catalysts driving both top and bottom-line growth,” Chan stated in the update. “These are exciting times for Sugarmade. We have…

Continue Reading

MondayOct 12, 2020 10:50 am

NetworkNewsBreaks – Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) Enters Definitive Agreements with New Cornerstone Shareholders

Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) today announced its entry into definitive agreements ("Definitive Agreements") with certain Barrick Gold Corporation subsidiaries and Augusta Investments Inc. in connection with the previously announced transaction pursuant to which Bullfrog will acquire rights to 1500 acres adjoining the company's Bullfrog Gold Deposit from Barrick, and Augusta and certain individuals identified by Augusta will concurrently complete a C$22 million investment in Bullfrog (the "Transaction"). "We are delighted to announce the signing of the Definitive Agreements and are encouraged by the positive market reaction to the announcement of the binding term sheet in…

Continue Reading

MondayOct 12, 2020 9:48 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights New Glioblastoma-Focused Segment Airing on Lifetime TV

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today highlighted a new segment from The Balancing Act titled, "Behind the Mystery," which will air on Lifetime TV and focus on glioblastoma. The segment, live this morning, follows the unique story of a glioblastoma patient and clinical insights regarding the rare and difficult-to-treat disease from Dr. Sigmund Hsu, a member of CNS Pharmaceuticals’ Scientific Advisory Board. In addition, a re-airing of the segment is planned for October 23, 2020. "It is encouraging to…

Continue Reading

FridayOct 09, 2020 12:11 pm

NetworkNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Featured in Simply Wall St Article

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company focused on the development of drug products for patients with high unmet medical need conditions or no alternative treatment options, was featured in a Simply Wall St article. The piece highlights PCSA Co-Founder Patrick Lin’s recent stock purchase at near current price. The article reads, “Potential Processa Pharmaceuticals Inc. (NASDAQ: PCSA) shareholders may wish to note that the Co-Founder, Patrick Lin, recently bought US$125k worth of stock, paying US$4.00 for each share. While that's a very decent purchase to our minds, it was proportionally a bit modest, boosting their holding by just…

Continue Reading

FridayOct 09, 2020 11:42 am

NetworkNewsBreaks – Cardiff Oncology Inc. (NASDAQ: CRDF) Announces Pricing of Underwritten Public Offering

Cardiff Oncology (NASDAQ: CRDF), a clinical-stage oncology therapeutics company developing drugs to treat cancers with the greatest medical need for new treatment options, recently announced the pricing of its previously announced underwritten public offering of 6,500,000 shares of its common stock at a public offering price of $13.50 per share. Cardiff Oncology anticipates receipt of approximately $88 million in gross proceeds from the offering, which is expected to close on or about October 2, 2020, subject to the satisfaction of customary conditions. The company has granted the underwriters a 30-day option to purchase up to an additional 975,000 shares at…

Continue Reading

FridayOct 09, 2020 11:10 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Begins Manufacturing of Lead Drug Candidate in Europe

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that its European manufacturer, BSP Pharmaceuticals S.p.A. ("BSP"), has begun the manufacturing process for Berubicin Drug Product, its lead drug candidate for the treatment of glioblastoma multiforme (“GBM”). GBM is an aggressive form of brain cancer currently considered incurable. “Our preparations for filing an IND for Berubicin require continued execution in both our clinical and manufacturing initiatives,” CNS Pharmaceuticals CEO John Climaco said in the news release. “With the manufacturing of our…

Continue Reading

FridayOct 09, 2020 10:29 am

NetworkNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Provides Update on Portfolio Expansion in the US

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today provided an update on the progress of three of its portfolio companies in U.S. markets. The updates come only weeks before the U.S. election, where six states will vote on cannabis legalization initiatives and the potential power shift at the federal level could lead to more progressive policies for the industry. Among the highlights, Canopy Rivers announced the following: TerrAscend Corp. commenced sales from its newly expanded State Flower cultivation facility in San Francisco; High Beauty Inc. introduced canBE, a new line of natural, aloe-based products…

Continue Reading